학술논문
Correction: Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity (Molecular Cancer, (2018), 17, 1, (50), 10.1186/s12943-018-0802-4)
Document Type
Erratum
Author
Source
In: Molecular Cancer . (Molecular Cancer, December 2023, 22(1))
Subject
Language
English
ISSN
14764598